Skip to main
GNMK
GNMK logo

GenMark Diagnostics (GNMK)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy GenMark Diagnostics (GNMK) Stock

About GenMark Diagnostics (GNMK)

GenMark Diagnostics, Inc. engages in the development, manufacturing, sales, and support of instruments and molecular tests based on its proprietary eSensor detection technology. Its solutions include ePlex System and XT-8 System. The company was founded by Jon Faiz Kayyem in 1993 and is headquartered in Carlsbad, CA.
Market cap$1.77B
Today's volume
Revenue (TTM)
Avg. daily volume3.05M
EBITDA (TTM)
Open
Price / earnings ratio-84.89x
Today's range
Debt / equity
52 week range$8.47 - $24.25
5 year debt / equity174.44x
Beta (LTM)0.52x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio
Ex-dividend date
Next earningsFeb 25, 2021
Dividend payable date

Frequently Asked Questions (FAQ)

As of Jul 11, 2025, the market cap for GNMK stock is $1.77B

The current P/E ratio for GNMK stock is -84.89

The 52-week high for GNMK stock is $24.25. The current GNMK stock price $undefined is 100.00% below its 52-week high

The 52-week low for GNMK stock is $8.47. The current GNMK stock price $undefined has increased 100.00% from its 52-week low

No, the GNMK stock does not pay dividends to its shareholders

How to buy GNMK stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in GNMK stock

    Navigate to the Explore page. Then, type GNMK into the search bar. When you see GNMK stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased GNMK stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

GenMark Diagnostics Stock Earnings

The value each GNMK share was expected to gain vs. the value that each GNMK share actually gained.

GenMark Diagnostics (GNMK) reported Q4 2020 earnings per share (EPS) of -$0.05, missing estimates of -$0.01 by 400.00%. In the same quarter last year, GenMark Diagnostics's earnings per share (EPS) was -$0.17. GenMark Diagnostics is expected to release next earnings on 02/25/2021, with an earnings per share (EPS) estimate of $0.

Buy GenMark Diagnostics (GNMK) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.